Caliway Biopharmaceuticals (6919.TW) Q4 2024 Earnings

8NovConfirmed
Q4 2024
-1.33
-1.19
-1.05
-0.91

Details

Expected EPS
-1.3274056818
Actual EPS
-0.9098707312332
Surprise EPS
0.42
Surprise Percent
+31.45%

Description

Caliway Biopharmaceuticals (6919.TW) has reported earnings of -0.9098707312332 per share for Q4 2024.

0 Comments

Share your thoughts